Description of the selected nodes. by Hanqing Guo (12451176)

“…The compaction rate initially increases and then decreases with different snow thicknesses; beyond the tread depth, the load significantly affects the maximum compaction rate, which reaches 504 mm/s. …”

Tailoring Ionic Conductivity of Polymeric Ionic Liquid Block Copolymers through Morphology Control by Samuel K. J. Adotey (22425591)

“…Transport-blocking defects are reduced by decreasing the molecular weight to achieve a weakly segregated state or by increasing the molecular weight to suppress diffusion and trap a morphology with only short-range order. …”

Finite Element Model of Tire and Snow Runway. by Hanqing Guo (12451176)

“…The compaction rate initially increases and then decreases with different snow thicknesses; beyond the tread depth, the load significantly affects the maximum compaction rate, which reaches 504 mm/s. …”

Yield Function of the MDPC Model [24]. by Hanqing Guo (12451176)

“…The compaction rate initially increases and then decreases with different snow thicknesses; beyond the tread depth, the load significantly affects the maximum compaction rate, which reaches 504 mm/s. …”

Alkenyl/Thiol Co-Functionalized Titanium-Oxo Nanoclusters Enable Synergistic Lithography for Enhanced Resolution and Sensitivity by Zuohu Zhou (14258773)

“…Such dual cross-linkable group functionalization brought additional thiol–ene click reactions upon exposure to enhance intercluster polymerization, which significantly improved the lithography sensitivity of TOCs, with the required exposure energy being reduced by over 70% (decreasing from >1000 μC/cm² of alkenyl-TOC to <300 μC/cm² of alkenyl/thiol-TOC). …”

Alkenyl/Thiol Co-Functionalized Titanium-Oxo Nanoclusters Enable Synergistic Lithography for Enhanced Resolution and Sensitivity by Zuohu Zhou (14258773)

“…Such dual cross-linkable group functionalization brought additional thiol–ene click reactions upon exposure to enhance intercluster polymerization, which significantly improved the lithography sensitivity of TOCs, with the required exposure energy being reduced by over 70% (decreasing from >1000 μC/cm² of alkenyl-TOC to <300 μC/cm² of alkenyl/thiol-TOC). …”

Alkenyl/Thiol Co-Functionalized Titanium-Oxo Nanoclusters Enable Synergistic Lithography for Enhanced Resolution and Sensitivity by Zuohu Zhou (14258773)

“…Such dual cross-linkable group functionalization brought additional thiol–ene click reactions upon exposure to enhance intercluster polymerization, which significantly improved the lithography sensitivity of TOCs, with the required exposure energy being reduced by over 70% (decreasing from >1000 μC/cm² of alkenyl-TOC to <300 μC/cm² of alkenyl/thiol-TOC). …”

(Related to Fig 2): The circadian DN1p and sCPDN3 signal to LPN. by Xin Yuan (174619)

“…(G, H) Optogenetic activation of sCPDN3 (<i>sCPDN3-spGal4>Uas-CsChrimson</i>; red line) significantly increases sleep compared to baseline. (I, J) Optogenetic activation of sCPDN3 (<i>sCPDN3-spGal4>Uas-CsChrimson</i>) significantly decreases daily locomotion compared to baseline (black bar). …”

Included studies basic characteristics. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

Forest plot for FVC. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

All data extracted. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

Forest plot for TNF- by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

Bias risk assessment of included studies. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

Forest plot for hs-CRP. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

Forest plot for IL-6. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

The incidence rate of adverse reactions. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

The PRISMA study flowchart. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

Forest plot for FEV1/FVC. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

Forest plot for clinical efficacy. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”

Forest plot for FEV1. by Xuqin Du (8803772)

“…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”